326 related articles for article (PubMed ID: 32239431)
1. Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma.
Manning P; Daghighi S; Rajaratnam MK; Parthiban S; Bahrami N; Dale AM; Bolar D; Piccioni DE; McDonald CR; Farid N
J Neurooncol; 2020 May; 147(3):681-690. PubMed ID: 32239431
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ASL and DSC perfusion methods in the evaluation of response to treatment in patients with a history of treatment for malignant brain tumor.
Bayraktar ES; Duygulu G; Çetinoğlu YK; Gelal MF; Apaydın M; Ellidokuz H
BMC Med Imaging; 2024 Mar; 24(1):70. PubMed ID: 38519901
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between radiation-induced brain injury and glioma recurrence using 3D pCASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging.
Wang YL; Chen S; Xiao HF; Li Y; Wang Y; Liu G; Lou X; Ma L
Radiother Oncol; 2018 Oct; 129(1):68-74. PubMed ID: 29398151
[TBL] [Abstract][Full Text] [Related]
4. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
[TBL] [Abstract][Full Text] [Related]
5. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.
Choi YJ; Kim HS; Jahng GH; Kim SJ; Suh DC
Acta Radiol; 2013 May; 54(4):448-54. PubMed ID: 23592805
[TBL] [Abstract][Full Text] [Related]
6. Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging.
Xiao HF; Chen ZY; Lou X; Wang YL; Gui QP; Wang Y; Shi KN; Zhou ZY; Zheng DD; Wang DJ; Ma L
Eur Radiol; 2015 Dec; 25(12):3423-30. PubMed ID: 26002128
[TBL] [Abstract][Full Text] [Related]
7. A radiomics-based comparative study on arterial spin labeling and dynamic susceptibility contrast perfusion-weighted imaging in gliomas.
Hashido T; Saito S; Ishida T
Sci Rep; 2020 Apr; 10(1):6121. PubMed ID: 32273523
[TBL] [Abstract][Full Text] [Related]
8. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI.
Wong AM; Yan FX; Liu HL
J Magn Reson Imaging; 2014 Feb; 39(2):427-33. PubMed ID: 23677620
[TBL] [Abstract][Full Text] [Related]
10. Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.
Qu Y; Kong D; Wen H; Ou X; Rui Q; Wang X; Lin DD; Qin Q; Wen Z
Eur Radiol; 2022 May; 32(5):2976-2987. PubMed ID: 35066634
[TBL] [Abstract][Full Text] [Related]
11. [Multi-parameter arterial spin labeling versus dynamic magnetic-sensitive enhanced cerebral perfusion imaging for diagnosis of transient cerebral ischemic attack].
Xu Y; Lv JH; Ma L; Chen WJ; Lou X
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):768-74. PubMed ID: 27320876
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Tumor Blood Flow Using Alternate Ascending/Descending Directional Navigation in Primary Brain Tumors: A Comparison Study with Dynamic Susceptibility Contrast Magnetic Resonance Imaging.
Park H; Lee J; Park SH; Choi SH
Korean J Radiol; 2019 Feb; 20(2):275-282. PubMed ID: 30672167
[TBL] [Abstract][Full Text] [Related]
13. Pediatric astrocytic tumor grading: comparison between arterial spin labeling and dynamic susceptibility contrast MRI perfusion.
Morana G; Tortora D; Staglianò S; Nozza P; Mascelli S; Severino M; Piatelli G; Consales A; Lequin M; Garrè ML; Rossi A
Neuroradiology; 2018 Apr; 60(4):437-446. PubMed ID: 29453753
[TBL] [Abstract][Full Text] [Related]
14. Differentiation between progression and pseudoprogresion by arterial spin labeling MRI in patients with glioblastoma multiforme.
Jovanovic M; Radenkovic S; Stosic-Opincal T; Lavrnic S; Gavrilovic S; Lazovic-Popovic B; Soldatovic I; Maksimovic R
J BUON; 2017; 22(4):1061-1067. PubMed ID: 28952228
[TBL] [Abstract][Full Text] [Related]
15. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors.
White CM; Pope WB; Zaw T; Qiao J; Naeini KM; Lai A; Nghiemphu PL; Wang JJ; Cloughesy TF; Ellingson BM
J Neuroimaging; 2014; 24(1):23-30. PubMed ID: 22672084
[TBL] [Abstract][Full Text] [Related]
16. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of perfusion-weighted imaging combined with serum MMP-2 and -9 levels in tumor recurrence after postoperative concomitant chemoradiotherapy of glioblastoma.
Liu W; Li Z
J Clin Ultrasound; 2023 Mar; 51(3):563-570. PubMed ID: 36435971
[TBL] [Abstract][Full Text] [Related]
18. Perfusion MR imaging of enhancing brain tumors: Comparison of arterial spin labeling technique with dynamic susceptibility contrast technique.
Soni N; Dhanota DPS; Kumar S; Jaiswal AK; Srivastava AK
Neurol India; 2017; 65(5):1046-1052. PubMed ID: 28879895
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of normal-appearing white matter with perfusion and diffusion MRI in patients with treated glioblastoma.
Şahin S; Ertekin E; Şahin T; Özsunar Y
MAGMA; 2022 Feb; 35(1):153-162. PubMed ID: 34951690
[TBL] [Abstract][Full Text] [Related]
20. The value of 3D pseudo-continuousarterial spin labeling perfusion imaging in moyamoya disease-Comparison with dynamic susceptibility contrast perfusion imaging.
Zhang H; Lu M; Liu S; Liu D; Shen X; Sheng F; Han C; Cai J
Front Neurosci; 2022; 16():944246. PubMed ID: 35992916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
